Raw_Activities
(12 lead) ecg¹
"(cleveland adolescent sleepiness questionnaire, sleep disturbance scale for children)"
"(dipstick): u-albumin, u-glucose, u-blood"
(prothrombin time)
1-point smpg profile
"1,5-ag"
"1,5-anhydroglucitol"
12- lead ecg (triplicate)
12-lead digital ecg
12-lead digital ecg (also printed on paper)
12-lead ecg
12-lead ecg (central reading)
12-lead ecg (local)
12-lead ecg locally
"12-lead ecg"",12-lead ecg (central or local)"""
12-lead ecg[
12-lead ecg*
12-lead ecg°
12-lead ecg¹
12-lead ecg³
12-lead ecgb
12-lead ecgd
12-lead ecge
12-lead ecgg
12-lead ecgi
12-lead ecgk
12-lead ecgp
12-lead electrocardiogram
12-lead electrocardiogram (ecg) locally
12-lead electrocardiogram (read locally)
12-lead electrocardiogram d
12-lead electrocardiogram² d
12-lead-ecg
"12-lead-ecg10,"
"12-lead-ecg4,"
12-lead-ecgh
1record weight and bmi at study visit wound
2-h standardized meal test
2-hour ppg test
2-point fsbg (pre-breakfast fbg and post- breakfast ppg) k
2-point profile
24-hour recall dietary assessment
24-hour urine collection instruction
24-hour urine for creatinine clearance and protein
24-hr blood pressure°
24-hr urine collection instructions/dispensing of containers?
"24-hr urine collection instructions/dispensing of containers"",""
nct03152084,"",24-hr blood pressure°"""
24-hr urine°
24-hr urinem
24h urine free-cortisol and creatinine*
25-hydroxy vitamin d
25-hydroxyvitamin d
2hpg (ogtt) 10.
4-point profile (smpg)
4-point smpgf
4-pt smbg°
6-minute walking test
7-9-7-point profile (smpg)
7-point profile
7-point profile³
7-point smbg
7-point smpg j
7-point smpg measurementk
7-point smpg profile
7-point smpg profiles (on 2 different days in the week prior to the visit)h
7-pt smbge
8-point smpg
9-point profile
9-point smpg profile
a body weight
"a1c"",""
nct02532855,labs"""
"a1c1,x"
a1c™
abbreviated
abbreviated physical exam
abbreviated physical examination
abbreviated physical examination including skin examination
abi eval²
abpm
abpm (cohort 1 only)
abpm device attachment and removal i
abpm placement°
abpm removal and assessment
active collection of adverse events
additional blood sample
addqol questionnaire
adherence to medications and side effects
adherence/lifestyle reinforcement
adjust cgm alert settings
adjust insulin dose (if applicable)
administer bexagliflozin
administer digoxin
administer imp(s)
"administer itsq m,n"
administer/dispense double-blind study drug
administer/dispense double-blind study drug¹
administration of trial product
administrative
admission
admission and discharge
admission or discharge³
admission to cru
admission to the unit
admission to/discharge from cru
admit to clinic
adult low blood sugar survey
adverse event
adverse event and concomitant medication
adverse event collection (aes and saes)
adverse event monitoring
"adverse event monitoring"",""
nct01986881,"",potential cardiovascular event assessment"""
adverse event recording
adverse event review
adverse event review (aes and saes)n
adverse events
adverse events (aes)
adverse events & dka assessments
adverse events assessment
adverse events assessments
adverse events g
adverse events including hypoglycemia
adverse events monitoring
adverse events monitoring g
adverse events u
adverse events/outcome events m
adverse events/pre-existing conditions
adverse events¹
adverse experience monitoring
advice on diet and exercise
ae
ae / sae
ae assessment
ae isae recording
ae monitoring
ae monitoring i
ae/sae review
ae/sae review and reporting
ae/sae/symptomatic hypoglycemia¹
aes and medication review
"aes, saes, aes of special interest review"
aes/sae eval
aes/saes
affirmation statement
age
albumin draw
albumin/creatinine ratio (urine) n
"alc: blood draw, lab handling and/or shipping of samples"
alcohol test and drug screen
allocation of e-code via ivrs/iwrs
"alogliptin or alogliptin fdcs status: dose, end date (if applicable"
alogliptin or alogliptin fdcs status: start date
alt
ambulatory
ambulatory bp monitoring device set up
amylase and lipase (predose)
"amylase, lipase"
"amylase, lipase and lactate (predose) a"
amylase/lipase
anti gad/fasting c-peptide
anti-hyperglycemic agents
anti-hyperglycemic medications(non-insulin)
anti-insulin antibody /
anti-insulin lispro antibodies
anti-lixisenatide and anti-insulin antibodies (only in frc group)
anti-sar425899 antibodies
anti-semaglutide antibodies
antibodies
antidiabetic medication
aortic compliance testing
"apoa1, apob, lp(a)"
appadl and iw-sp questionnaires
"archived samples (plasma, serum, and urine samples) for exploratory analysis'"
assess adverse events/serious adverse events
assess aes
assess compliance
assess compliance to investigational product
assess compliance with blinded investigational product
assess compliance with blinded study drug¹
assess compliance with double-blind study medication and
assess compliance with investigational product
assess compliance with single-blind placebo run-in
assess eligibility
assess fpg for rescue
assess study drug compliance
assess study drug compliance i
"assess subjects for potential rescue or discontinuation from blinded investigational product, based on central laboratory fpg/a1c"
assess trial medication compliance. collect unused and used investigational product / open label liraglutide
assessment (revised per amendment 01)
assessment for necessity of rescue treatment (up- titration of insulin agents)
assessment of aes and saesd
assessment of aes/saes
assessment of aes/saes c
assessment of endothelial function using endo-pat
assessment of investigational product compliance
assessment of need for rescue therapy
assessment of signs and symptoms
assessment of signs and symptoms of hypoglycemia episodes
assign e-code
assign subject id
assignment of randomization number
assignment of screening number
assignment of treatment number
assignment of treatment/randomization number
attend blood sampling fasting
attend visit fasting
attend visit fasting h
"attend visit fasting"",""
nct02827708,"",basal insulin dosed"""
barriers in diabetes treatment
barriers in diabetes treatment questionnaire
"basal (fasting) and 4hr mmtt stimulated glucose, ffa and c-peptide"
basal insulin dose information
basal insulin dose titration
baseline signs and symptoms
baseline signs/symptoms(
baseline signs/symptoms['
basic fasting lipid panel
basic physical exam
"bg meter, instructions"
"bg meter/supplies, if needed"
"bhi 30, date and dose"
bio-impedance analysis
biochemistry
biochemistry f
"biochemistry parameters 6,"
biochemistryb
bioimpedance spectroscopy
bioimpedance spectroscopyp q
biomarker sample collection
biomarkers
biomarkers (blood)
blinded investigational product administration
"blood (deoxyribonucleic acid, dna) for fbr"
blood (dna) for future biomedical research
blood (dna) for future biomedical researche
blood (dna) for genetic analysis
blood and urine analyses (except safety analyses)
blood cell count
blood chemistries** (local measure)
blood chemistry
blood chemistry (fasting)
blood chemistry[
blood chemistry¹
blood draw
blood draw for clinical lab test
blood draw for clinical lab tests
blood electrolytesp
blood for genetic analysis
blood for genetic analysis*
"blood for glucose analysis"",""
nct03170544,"",blood for non-esterified fatty acids (nefa)"""
blood for glucose bedside analysis o
blood for glycerol
"blood for plasma mk-1092 and/or metabolites assay and glargine1,m"
"blood for plasma mk-5160 and/or metabolites assay or glargine k,"
blood for serum anti-glargine (insulin) antibody//immunogenicity assay
blood for serum anti-mk-1092 and anti-glargine (anti-insulin) antibody/ /immunogenicity assay
blood for serum anti-mk-5160 antibody/immunogenicity assay
blood for serum c-peptide
blood for serum insulin
blood for triglycerides
blood glucose meter dispensing and training
blood pressure
blood pressure and pulse ratea
"blood pressure, heart rate and body weight"
"blood pressure, pulse rate("
"blood pressure, sitting"
blood sample
blood sample for measurement of inflammatory biomarkers and isolation of wbcs
blood sample for pk
blood samples for fpg
"blood samples for glp-1, i glucagon, gip"
"blood samples for glucose, i insulin, pro-insulin, c-peptide"
blood samples for hba1c
blood samples for hematology and additional clinical chemistry
blood samples for pk
blood samples for s-creatinine (egfr calculation)
blood samples for safety laboratory panel
blood sampling
blood sampling for hormones
blood sampling for limited pk
blood sampling for pki
blood sampling for platelet activity parameters
"blood sampling for serum chemistry, hematology, fpg, hba1c, hcg, tsh, t3, and t4 2)"
"blood sampling for zinc, insulin, adiponectin, c-peptide, leptin, glucagon, (chp in a subset of subjects 3)"
blood sampling for:
bmdp
bmi
bnp
body height
"body height, body weight and bmi calculation"
"body height, body weight, and bmi calculation"
body mass index
body measurement
body measurements
body weight
body weight (measured in
body weight (measured in duplicate)
body weight and height c
"body weight, bmi"
"body weight, height"
"body weight, heightc"
"body weight, heighte"
"body weight, waist"
body weighta
bone age
bone markers
bone metabolism markers
breath alcohol assessment
breathalyzer
brief physical assessment (at the investigator's discretion)
brief physical exam³
brief physical examination
brief physical examination f
brief physical examination°
brief physical examination¹
brief physical examk
"brief visit w/vitals, weight, foot examination°"
briefing of patients by the study dietician regarding food boxes
c optional future genetic research
c optional future non-genetic research
c-peptide
c-peptide (fasting)
c-peptide sampling¹
c-peptide¹
c-ssrs and self harm supplement form
calcitonin
calcitonin blood sample
calcitonin c
calculate egfr
calculate egfr to confirm eligibility
calculation of average total daily insulin dose
capillary blood glucose at clinic
cardiovascular history
cardiovascular testsh
case book sign off
categorical assessment of injection site pain intensity
"cbc, lft, pregnancy"
"cbcp, fbg, comprehensive metabolic profile, lipid profile, and urine albumin excretion"
cc
cci
central laboratory
central laboratory testing
cgm
cgm and glucose meter training
cgm and pen data download
cgm device demonstration
cgm device inserted for 6-day cgm glucose measurements (patient calibrates device using glucometerd)
cgm device removed and data downloaded from cgm device and glucometer
cgm informed consent
cgm measurement
cgm monitoring
cgm provided
cgm returned
changes in lab tests
check ability to self-administer investigational product d
check inclusion/exclusion criteria
check smpg technique (training as needed throughout the study)
"check subject's ability to self-administer sc injection"",""
nct03235050,"",provide education on diet and exercise"""
chemistry
chemistry (including amylase and lipase)
chemistry group
"chemistry laboratory tests e,f"
chemistry panel
"chemistry panel j, k"
"chemistry, hematology, urinalysis, lipids"
child bearing potential
child bearing potential/pregnancy
child-bearing potential
childbearing potential
circumference
clamp protocol
clamped euglycaemia including assessment of gfr
clinic procedures/assessments
clinic visit
clinical and sae event assessment
clinical assessments
clinical assessments:
clinical chemistry
clinical chemistry and haematology
"clinical chemistry, hematology"
clinical chemistry/hematology
clinical chemistry/hematology samples
clinical drug supplies
clinical examination
clinical laboratory assessments
clinical laboratory tests
clinical laboratory testsb
clinical laboratory testsf
clinical laboratoryd
clinical procedures
clinical procedures/assessments
clinical safety laboratories*
clinical variables
closure assessment
coagulation
coagulation panel'
coagulation panel¹
coagulation studiesk
cognitive function (dsst)
cognitive function (moca)
collect (unused) study drug
collect aes
"collect and review available information including most recent hba1c, serum creatinine and lipid profile"
collect and review diary
"collect and review subject loge (smbg values, hypoglycemia, and insulin doses) and download glucometer"
collect blood for:
collect first date and dose of trial product
collect glucose meter
collect glucose meter/unused supplies
collect injection pen
collect instructions for user
collect last date and dose of trial product
collect study diaries/food and exercise worksheets
collect study drug
collect study medication
collect unused study medication
collect unused study medication/supplies
collect urine for:
collect urine sample for:
collect used/unused ipr
"collect, review and transcribe diaries"
collect/review diary
collection and review of hal
collection and review of patient's log
collection of ae/sae
collection of ae/saey
collection of diary
collection of glucose meter (if mandatory by local regulation)
"collection of home urine for albumin, creatinine, calcium, phosphorus, magnesium, glucose, and albumin-creatinine ratio"
collection/reporting
company confidential information
comparative pain assessment
complete
complete medical history
complete physical examination
complete physical examination (including screening for diabetic neuropathy)
complete physical examination 5 including skin examination
complete physical examination including skin examination
compliance
compliance check
"compliance check (review of diary, returned imp)"
compliance check (review of diary)
compliance: count returned imps
comprehensive physical exam
con med
con meds log
concom meds
concomitant illness
concomitant illness and medical
concomitant illness and medical history
"concomitant illness, medical history"
concomitant illness/medical history
concomitant medication
concomitant medication (diabetes)
concomitant medication (including oams)
concomitant medication and non drug supportive interventions
concomitant medication assessments
concomitant medication including antihypergycemic medication
concomitant medication recording
concomitant medication review
concomitant medication review (including any dose changes to medications for diabetes)e
concomitant medication/(aad dosing)b
concomitant medications
concomitant medications and non drug supportive interventions²
concomitant medications review
concomitant medications²
concomitant therapies
concomitant therapy
confirm competency with injections [3]
confirm eligibility
confirm final eligibility
confirm pen operation
confirmation of diet and exercise therapy
confirmation of liraglutide dose
confirmation of metformin dose
confirmation of unchanged dose of metformin
confirmation of unchanged metformin
confirmation of unchanged metformin dose
confirmation of unchanged oads
conmed assessment
consumption of food from food boxes
contact ivrs
contact ivrs system
contact ivrs/iwrs
contact iwrs
contact ixrs
continuous glucose
continuous glucose monitoring
"continuous glucose monitoring, fitting and training"
"continuous glucose monitoring, sensor check"
"continuous glucose monitoring, upload"
counsel subject to switch current aha or adjust background metformin (if applicable)
counseling for diet & exercise and for hypoglycemia recognition & treatment
count returned pens
counting / collecting used and unused study medication d
"counting / collecting used, unused and in use pens"
"country-relevant information: alogliptin or alogliptin fdcs market status, t2dm standard of care"
creatinine
creatinine (including egfr)
creatinine (to calculate crcl and egfr)
criteria for premature discontinuation of trial product
cross-over
crp
cru admission
cru discharge
ct or mri scan or equivalent
ct-pet/mri-pet (fasting)
"ctx, p1np, pthv"
current diabetes treatment
current medical conditions
cv risk factor history
cycloset titration
cystatin c
d drug and alcohol screen
dae
daily fasting smpg measurement.
dapagliflozin pkb
dapagliflozin pkj
data from glucometer readings downloaded to system or entered manually
data from patient log sheets entered manually into the system
date of diagnosis of diabetes
date of diagnosis of diabetes/diabetes complications
date of final dose of study drug recorded
date of first dose of study drug recorded
demographic (including height)
demographic data
"demographic data2,"
demographics
demographics & medical history
demographics and medical history
"demographics, medical history"
demography
demography and medical history
"demography, height (measured in duplicate), & medical history including smoking status"
"demography, height in duplicate & medical history including smoking"
"demography, history of diabetes, medical history"
"demography, medical history"
"demography, medical history, diabetes history"
"demography, medical history; diabetes history, prior medications"
"demography, medical/disease history"
"demography, tobacco use"
demography/medica history
dexa
dfs-sf admin
diabetes complications
diabetes history
diabetes history and diabetes complications
diabetes history/ diabetes complications
diabetes history/diabetes
diabetes history/diabetes complications
diabetes management education g
diabetes management educationh
diabetes medical history/therapy
diabetes mellitus complications
diabetes pen experience measure
diabetes treatment
diabetes treatment history
diabetes treatment satisfaction questionnaire
"diabetes: diagnosis, complications and treatment history"
diabetes/medical history/therapy
diabetic ketoacidosis events
diagnosis
diagnosis of diabetes
diagnosis of diabetes and diabetes complications
diagnosis of diabetes/ diabetes complications
diagnosis of diabetes/diabetes complications
diagnostics (efficacy)
diagnostics (safety)
diary & glucometer record review
diary and glucometer dispensation
diary and glucometer dispensation and review
diary and glucometer record review
"diary collect, review, transcribe"
diary collection/review
diary dispensation / collection (reviewed at each on-site visit)
diary dispense and instruct
diary reviews at visits
diary training and dispensed
diary use trainingb
diastolic blood pressure
"diastolic blood pressure, sitting"
diet & exercise counseling
diet & exercise counseling²
diet & exercise instruction
diet and activity counseling/ monitoring
"diet and activity counseling/monitoring"",""
nct02492763,"",dispense hypoglycemia assessment log (hal) and instruct on hypoglycemia symptoms and management"""
diet and activity counseling/monitoring*
diet and exercise and smpg trainings
diet and exercise counseling
diet and exercise counseling ($2)/monitoring
"diet and exercise counseling (s2)/monitoring"",""
nct02033889,"",distribute glucose meter (s2) and glucose meter supplies"""
diet and exercise counselingad
diet and exercise counselling
diet and exercise counselling c
diet and exercise counselling¹
diet and exercise therapy monitoring
diet and lifestyle advice
diet and lifestyle counseling
diet and lifestyle counselling
"diet, exercise, bg counseling"
diet/exercise counseling (v2)/monitoring (other visits)
diet/exercise/smbg advice/reinforcement
dietary advicee
dietary and life-style advice
dietary counseling
dietary evaluation
digital 12-lead ecg
dipstick urinalysis
direction for use (dfu)
discharge
discharge from clinic
discharge from cru
discharge from the unit
discharge from unit
discontinuation/withdrawal criteria
discontinue dpp4i
discontinue non-metformin oha
discuss individual targets for glucose control (fpg and hba1c)
disease assessments
dispensation diary
dispensation of glucometer
dispensation of imp
dispensation of study glucometer and e-diary
dispensation of study medication
dispensation of study medication via ivrs/iwrs
dispensation of study medicationg
dispense and review daily log
dispense and review medications
dispense and/ or collect diary
dispense and/or collect diary
dispense bexagliflozin
dispense blinded glimepiride/placebo for non- rescued subjects or continued open-label glimepiride for subjects rescued in phase a
dispense blood glucose meter / provide self- monitoring blood glucose (smbg) instruction
dispense containers for urine sample collection
dispense diary
dispense diary & glucometer
dispense direction for use/package leaflet
dispense directions for use
dispense double-blind ertugliflozin/placebo
dispense double-blind i study medication
dispense double-blind imp
dispense double-blind investigational product
dispense double-blind investigational product / open-label liraglutide
dispense double-blind medication
dispense double-blind study drugh
dispense double-blind study medication
dispense empagliflozin/ placebo
dispense glimepiride
dispense glimepiride glycemic rescue medication as appropriate
dispense glucometer and/or supplies; provide instructions
dispense glucometer and/or supplies/instructions
dispense glucose meter
dispense glucose meter and provide smbg instruction
dispense glucose meter and supplies
dispense glucose meter and/or supplies (including diaries) /provide instructions
"dispense glucose meter, fingerstick glucose logs, and provide smbg instruction"
dispense glucose meter/supplies
dispense glucose monitoring and ancillary supplies
dispense glucose testing supplies and first study diarybb cc
dispense glucose testing supplies and first subject diary
dispense glycemic rescue medication as appropriate
dispense hypoglycemia assessment and self- monitoring blood glucose logs and instruct on hypoglycemia (symptoms and management) and hyperglycemia symptoms
dispense hypoglycemia assessment log (hal) and instruct on hypoglycemia symptoms and management
dispense imp
dispense investigational product
dispense lithium tablet¹
dispense medication
dispense of tactipen f
dispense open label rescue medication (if necessary)
dispense patient diary
dispense pg meter/supplies
dispense pg meter/suppliesg
dispense placebo run- in medication i
dispense placebo run-in medication
dispense placebo run-in medication (via ixrs)
dispense pre-filled pens
dispense ramipril
dispense rescue medication (if needed)
dispense run-in medication
dispense single- blind placebo
dispense single-blind imp
dispense single-blind placebo
dispense single-blind placebo run-in
dispense single-blind placebo run-in investigational product
dispense single-blind run-in medication
dispense study diary and instruct to use
"dispense study diary, instruct in use"
dispense study drug
dispense study drug and/or injection supplies
dispense study drug diary
dispense study drug i
dispense study drug/injection pen
dispense study drugs and/or injection supplies
dispense study drugt
dispense study medication
dispense study medication (irt)n
dispense study treatment
dispense subject id card
dispense subject identification card
dispense trial product. instruct and hand out directions for use.
dispense/administer drug
dispense/review self monitoring blood glucose and hypoglycemia assessment log
dispensing hal
dispensing investigational product
dispensing of investigational product and injection supplies
dispensing of smpg meter/supplies
dispensing of trial product
dispensing run-in drug
dispensing study diary and instruct in use
dispensing trial product
dispensing visit
distribute glucose meter (s2 only) and glucose meter supplies (other visits as designated)
distribute sponsor-provided glucose meter (v2) and glucose meter supplies
distribute study diaries/food and exercise worksheets
dna
dna collection
documentation of the imp dose
dose adjustment criteriad
dose of current diabetes treatment
dose of trial insulin
dose of trial insulin8
dose of trial product to be
dose-finding
dosing dates
double tracer ogtth with ic
drug
drug accountability
drug accountability (iwrs)
drug accountability (pill count)
drug accounting & compliance e
drug and alcohol screen b
drug dispensation
drug return and accountability
"dtr-qol, dtsqs"
dtsqc
dtsqc (change version)s
dtsqs
dtsqs (status version)9 habs
duplicate)
duration of diabetes
duration of pain
duration of pain¹
dxa for body composition
dxa for body composition measurements
dxa scan
dxak
e pregnancy test
e-diary dispensing and training
ecg
ecg (12-lead)
ecg (local)
ecg 12 lead
ecg b
ecg e
ecg evaluation
"ecg,"
ecg³
ecge
ecgs b
echocardiogram
echocardiogram for assessment of left ventricular function c
echocardiogramd
ecog performance status
effectiveness endpoints
efficacy
efficacy assessments
efficacy measurements
egfr
egfr (ckd-epi) o
egfr (ckd-epi)¹
egfr (mdrd)
egfr and serum creatinine
egfr°
egfr¹
egg /water load / vas³
electrocardiogram
electrocardiogram d
electrocardiograme
electrocardiography
eligibility check
eligibility criteria
employment/ disability/ambulatory
end of treatment
end of trial
end of trial (subject completion)
end of trial and sign off case book
end of trial and sign off on case book
end of trial form
end treatment
endocrine function assessment
endocrinological³
endpoints and adverse events assessment
enrollment
"ensure breakfast drink"",""
nct03531905,"",ppg glucose sample"" n"""
entry criteria
entry criteria reviewed
eq-5d completion
eq-5d-3l
"erectile function (iief), men only"
estimated glomerular filtration rate (egfr)
estradiol and fsh (females only: if required)
"estradiol, fsh, lh¹"
"euglycemic clamp/ infusion of glucose"",""
nct03170544,"",blood for glucose bedside analysis°"""
euglycemic clamp/infusion of glucose m
evaluation of injection site reactions
events c
events in cv composite endpoint
exclusion criteria
expiratory flows
exploratory biomarkers
extended urinalysis e
eye examination
eye examination d
eye examination h
eye examination10 (fundoscopy/fundus photography)
f safety lab tests (urine and blood)
f screening laboratory tests
f telemetry
family history of diabetes
family history of t2dm
fasted home blood glucose monitoring (hbgm) g
fasted home blood glucose monitoring'
fasting
fasting blood glucose d
"fasting blood sample for c-peptide and insulin, glp-1 and glucagon"
fasting c-peptide
fasting c-peptide°
fasting condition visite
fasting fingerstick glucose
fasting fingerstick glucose in clinic
"fasting fingerstick glucose l,m"
"fasting fingerstick glucose m"""
fasting glucagon
fasting glucose
fasting human insulin
fasting insulin
"fasting insulin (potential analysis, for archive) and c-peptide"
fasting insulin and c-peptide
fasting insulin and glucose
fasting insulin and pro-insulin
fasting insulin and proinsulin
"fasting insulin for calculation of homa-ß, homa-ir"
fasting insulin levelt
fasting level of adiponectin
fasting lipid panel
fasting lipid profile
fasting lipid profilew
fasting lipids
fasting lipids'
fasting plasma glucose
fasting plasma glucose (central lab)
fasting plasma glucose (fpg)
"fasting plasma glucose"",glucose"""
fasting plasma glucose¹
fasting pro- insulin
fasting proinsulin
"fasting safety lab tests (chemistry, hematology)"
fasting safety lab tests (chemistry)
fasting safety lab tests (hematology)
"fasting serum c-peptide, insulin, (subset of subjects at sites that elect to participate)"
fasting serum for storage**
fasting serum glucose
fasting serum lipid profile
fasting serum lipids
fasting serumc chemistries
fasting smpg measured at least three times per week before breakfast
fasting smpg measured every day before breakfast
fasting triglycerides
fasting triglycerides/tsh
fasting triglycerides/tsh/pth
fasting visit
fasting visits
fasting weight a
"fasting weightc, height"
ffa
ffa and ketone bodies
ffq
fgm fitting
fgm sensor data
fibrinogen
fingerstick glucose testing
first date on trial product
first day of most recent menstrual period
first dose on trial product
first morning void for albumin/creatinine ratiosx
"first morning void urine for albumin/creatinine ratiom,"
"flash glucose monitoring, fitting"
"flash glucose monitoring, removal and upload"
flow mediated dilatation (fmd)
follicle stimulating hormone (if necessary per inclusion criteria)
"follicle stimulating hormone, if necessary per inclusion criteria)"
follicle-stimulating hormone test
follicle-stimulating hormone testo
"follow-up /vitals, foot examination"
"follow-up for axitinib dosing compliance [i]"""
follow-up for dosing compliance [12]
food intake booklet completion
"food intake questionnaire"",""
nct01243424,study procedures """
"food intake questionnaire"",""
nct03152084,study procedures """
for clinical chemistry and haematology¹
for clinical chemistry and haematologyb
for liraglutide arm: confirmation of unchanged dose 8 of liraglutide
fpg
fpg (central laboratory)
fpg (central laboratory) (a 1-time repeat measurement before visit 2 is permitted)
fpg (local laboratory)
fpg sample
fpg/ketones
free fatty acids
fructosamine
fsh (if applicable)
fsh h
fsh lh
fsh/lh or estradiolh
full (f) or brief (b) physical
full (f) or brief (b) physical exam²
full physical exam
full physical examination
full physical examination (excluding rectal and urogenital examination)
full physical examination (including structured neurological examination) a
"gabr, biochemical markers of endothelial function (svcam-1, sicam- 1, vwf)"
gad/ia2 autoantibodies
gallbladder disease history
gcsi-dd
gebt³
gender
general
general medical history and prior medications²
general procedures:
genetic blood sample
genetic informed consent
genetic sample
genetics sample
glomerular filtration rate m
glomerular filtration ratek
glu30 (ogtt)
glucagon
"glucagon receptor activation biomarkers (including ketones, glucagon, fgf-21 and kisspeptin) (potential analysis, for archive)"
glucometer (one touch ultra) and strips distributed
glucometer dispensation & training (including training on glucose measurements)
glucometer measurement
glucometer provision/training
glucometer training and dispense
"glucometers, smpg, hypoglycemia, insulin dose titration, diary training and re-training"
glucose
glucose (fasting) m
glucose clamp procedures
glucose metabolism
glucose meter dispense and instruct
glucose profile review and insulin titration
glucose turnover study¹
glycated hemoglobin (hba1c
glycemic control
glycerol
h pk for medi
h pregnancy test
haematology
haemoglobin
hand out and instruct in bg meter
hand out and instruct in bg meter use
hand out and instruct in bg-meter
hand out and instruct in diary
hand out and instruct in pro device
hand out direction for use
hand out directions for use
hand out id card
hand out of subject id card
hand-out and /or collect diary
hand-out and instruct in bg meter
hand-out and instruct in diary
hand-out and instruct on bg meter use
hand-out bg meter
hand-out directions for use
hand-out id card
hand-out/instruction/collect diary
handling/training of product/device
handout and instruct in bg meter use
handout and instruct in bg-meter use
handout and instruct in blood glucose meter use
handout and instruct in diary
handout and instruct in/collect diary
handout and/or collect diary
handout id card
hba
hba 1c
hba1 e
"hba1,"
hba1c
hba1c (central lab)
hba1c (central laboratory)
hba1c (predose) a
hba1c & fpg
hba1c draw
hba1c sampling
"hba1c, fasting glucose"
hba1c/c peptide
"hba1c6,"
hbal
hbalc
hbalc (screening)
"hbalc and fasting blood glucose levels6,"
hbalc blood draw a
hcv antibody testing
hcv viral load
health care utilization
health economic assessment
"health habits (alcohol use yes/no, tobacco use current/past)"
"health habits (alcohol use, tobacco use current/past)"
"health habits (alcohol, tobacco)"
health outcome questionnaires/other evaluation
health status (general and t2dm related)
healthcare resource utilization
"healthcare resources utilization: number of hospitalizations (including length of stay during each hospitalization, reason, and urgency [urgent/not urgent]), er visits, and physician office visits"
heart rate and blood pressure a
heart rate)
height
"height (h), weigh (w), bmi"
height (measured in duplicate)
height a
height and bmi
height and weight
height and weightd
height and weighte
height without shoes
"height, weight, bmi"
"height, weight¹, bmi"
heightd
hematology
hematology (predose) a
hematology and chemistry
hematology and coagulation panels
hematology clinical chemistry(centra lab)
"hematology j, k"
hematology laboratory testse
hematology panel (predose as applicable)
"hematology, blood chemistry, serum lipids, and glycemic control assessments"
"hematology, chemistry panel"
"hematology, clinical chemistry, endocrinology, hba1c d"
"hematology, liver enzymes, creatinine"
"hematology"",hematology"""
hematology(
"hematology(1, clinical chemistryn"
hematology[
hematology/chemistry/urinalysis²
hematuria dipstick urinalysis
hematuria microscopic urinalysis*
hemoglobin (local measure)
hemoglobin a1c
hemoglobin a1c (a1c)
hemoglobina1c e
hemogram (cbc) w/ plate & auto diff
hepatitis and hiv screen
hepatitis b and c serology b
hepatitis b and c testing [hepatitis b surface antigen and core antibody; anti-hepatitis c antibody]
hepatitis b and hepatitis c
hepatitis b and hiv test
hepatitis b surface antigen and hepatitis c antibody
"hepatitis b, c, hiv"
hepatitis screen
hepatitis screen panel
hepatitis screening panel
"hepatitis screening panel, tsh"
hepatitis screening panel¹
hepatitis serology
high-fat meal administration
hip / waist measurements
hip and waist circumference
hip measurement
hipaa
history of cardiovascular disease
history of diabetes
history of gallbladder disease
history of gastrointestinal disease
hiv-1 and hiv-2 antibodies
hiv-antibodies?
"hiv, hepatitis b and c, amylase, alcohol and drug screen, tsh"
hiv/hepatitis screen (per site sop)
holter monitor
home blood glucose monitoring h
home blood pressure monitoring
"home blood pressure monitoring, pulse rate [10]"
home monitoring
hormones
hormones (calcitonin)
"hormones, calcitonin"
hour urine collection
hscrp
hscrp (highly sensitive crp)
hyperglycemic clamp & air max
hyperinsulinemic hypoglycemic clamp (see below)
hyperinsulinemic-euglycemic clamp investigation
hyperinsulinemic-hypoglycemio clamp investigation
hypersensitivity reactions
hypoglycaemia unawareness
hypoglycaemic episodes
hypoglycaemic events
hypoglycaemic unawareness
hypoglycemia
hypoglycemia events
hypoglycemia patient questionaire
hypoglycemia recording
hypoglycemia review of electronic sourcea
hypoglycemic confidence scale
hypoglycemic episodes c
hypoglycemic episodes h
hypoglycemic events
hypoglycemic events review
i mmt
"if consent obtained, blood sample (serum and plasma) and urine sample for archive"
"if consent obtained, collect blood sample for genetic and genomic analysis"
ilistory of gallbladder disease
immunogenicity
immunogenicity assay (anti-drug ab)
immunogenicity blood sample
immunogenicity sample
immunogenicity testing
imp (sar341402 or novolog/novorapid)
imp accounting & compliance
imp administration
imps dispensation
"in clinic blood pressure, pulse rate [9]"
in clinic meal
in- and exclusion criteria
in-/exclusion criteria
in/exclusion criteria
inc./exc. criteria
inc/exc criteria
inclusion / exclusion criteria
inclusion and exclusion criteria
inclusion criteria
inclusion/ exclusion criteria
inclusion/exclusion
inclusion/exclusion criteria
inclusion/exclusion criteria b
inclusion/exclusion criteria review¹
inclusion/exclusion criteriab
infectious disease testing
inflamm. markers in exhaled air
inform about eligibility
information about trial product handling
informed consent
informed consent (before procedures/tests)
"informed consent (written, general)"
informed consent and hippa¹
informed consent d
informed consent for future biomedical research
informed consent for future biomedical researchd
informed consent for future biomedical researche
informed consent for optional samples
informed consent for study
informed consent form (icf)
informed consent[
informed consent[5]
informed consent/assent**
informed consent/hipaa [2] and stored blood sample authorization
informed consent¹
informed consent²
informed consentd
"initial physical examination/vitals and weight, foot examination"
injectable therapy dose (day prior to visit)i
injection at study site f
injection site assessment
injection site local tolerability assessment
injection site local tolerability assessment f
injection site reactions
injection training g
injection training/instruction (to be repeated as needed throughout the study)
injection trainingh
injection-site assessments
injection/pen training
instruct in bg meter use
instruct on glucose meter
instruct on hypoglycemia
instruct on/reinforce lifestyle modification plana
instruct self- administration of medication
instruct/review injection h
instruction on basic genito-urinary hygiene & hydration
instruction on basic genitourinary hygiene & hydration
instruction on diabetic ketoacidosis symptoms and glucose testing
"instruction on diabetic ketoacidosis symptoms, glucose testing"
"instructions on hypoglycemic symptoms, management, and recording of hypoglycemic assessment log (hal)"
insulin
insulin & glucagon
insulin antibodies
insulin dose
insulin dose collected i
insulin dose d
insulin lispro pk sampling
insulin pen instruction
insulin preference questionnaire
insulin therapy dose (day prior to visit)
insulin treatment c
intensity of injection site pain vas
interactive response technology (irt) contact
intervention period
investigational product
investigational product administration
investigational product administration h
investigational product/rescue
ip administration
ipragliflozin for the study dispensing
irt call
irt contact
itsq
iv infusion of dextrose
iv infusion of insulin
iv/iwrs call
iv/wrs call
ivrs call
ivrs/iwrs call
iwrs
iwrs call
iwrs log-in
iwrs session
ixrse
j
jardiance administration status
jardiance duo® administration status
k ada
k pk
katz-adl admin
ketone bodies
ketone measurement at the site³
ketones (b-hydroxybutyrate)
lab assessments
lab procedures/assessments
laboratory
laboratory assessments
laboratory assessments k
laboratory assessmentsk:
laboratory procedures/assessments
laboratory sampling
laboratory specimen collection
laboratory studies
laboratory testing (central lab)
laboratory testing:
laboratory testingh
laboratory testingk
laboratory tests
laboratory tests (biochemical)
lactate (predose as applicable)
lactate¹
lantus or ly2963016 administration (0.5 u/kg single dose sc)
last date on trial product
"last date, dose and time point on trial insulin"
last dose on trial product
lead-ecg
letter to physician
lifestyle counseling
limited physical exam
lipase and amylase
lipid lab panel
lipid panel
lipid panel (fasting) m
lipid panel (including free fatty acid)
lipid panel and apolipoproteins
lipid panel and fpg
lipid panel i
lipid panel¹
lipid panelp
lipid profile
lipids
lipids (fasting)
lipids (fasting)°
"lipids (including total cholesterol, hdl c, triglycerides, ffas)"
"lipids (including total cholesterol, ldl-c, hdl c, triglycerides, ffas)"
lipidsh
liraglutide antibodies
liraglutide/placebo dispensed
"liver function parameters (ast, alt, ggt)"
liver function test
local urine pregnancy
local urine pregnancy test b
log provided
lower limb examination
lvef assessment
ly3202626 administration
ly3209590 pk
main informed consent
make appointment for eye examination
markers of bone & calcium metabolism(
markers of bone & calcium metabolismo
markers of intestinal transit & absorption
meal test
meal tolerance test (mtt)
measure weight
med/surg/social history
medi0382 ada d
medical and disease history
medical and disease history (including smoking and alcohol history)
"medical and disease history (including smoking, drug, and alcohol history)"
medical and surgical history
medical assessment
medical history
medical history (general)
medical history (includes substance usage and history of cv disease)
medical history (including smoking and alcohol history)
medical history / concomitant diagnoses
medical history /concomitant illness
medical history & demographics
medical history and comorbid conditions
medical history and demographics
medical history and icf
medical history and physical examination
medical history questionnaire
medical history/ concomitant diagnoses
medical history/ concomitant illness
medical history/current medical conditions
medical resource utilization
medical/medication history
medical/oncological history [°]
medical/oncological history [6]
medical/surgical history
medication adherence
medication compliance check
medication compliance monitoring (study medication and insulin)
medication error
medication history
medication inventory
medication prescribed
mixed meal test
mixed meal tolerance test
mixed meal tolerance test (mmtt)
mk-1092/glargine administration
mk-5160 or glargine administration
mmt and blood samples for glucose metabolism i panel
mmt and blood samples for glucose metabolism panel i
mmtt extended
mmtt°
modified diet'
monitoring g
mri
mri (fasting)
mtt e
mtt test
nefa
new dose of trial insulin
nimp (lantus)
nocturnal oxygen saturation
non-study medication review
non-study therapy (establish metformin at stable dose and continue it on trial)
nonpharmacogenetic
nonpharmacogenetic biomarker (plasma and serum)
"nonpharmacogenetic biomarkers sample storage (plasma, serum, urine)"
nonpharmacogenetic samples
nonpharmacogenetic stored samples
notes made if change in metformin dose or treatment
nt-probnp
nyha classification
oad dose (day prior to visit)
oam washout
observe patient inject study drug
observe patient inject study drug h
obtain informed consent
obtain written assent (if applicable)
off-site phone visit
offer to enroll in psp
office or home visit
offloading instruction and documentation
ogtt
ogtt 4)
once daily
once daily¹
ongoing review
ophthalmologic examination
optional future genetic research
optional future non-genetic research c
optional informed consent for sample for future genetic research
orthostatic bp and pulse
"orthostatic vital signs (heart rate, blood pressure)"
"osteopontin, fgf-21 (active), adiponectin, ß-hydroxy butyrate, glycerol, free fatty acids, mcp-1, ctx-1, p1np, osteocalcin"
other
other - transfer data to ecrf (inform)
other assessments
other biomarker sampling (where applicable)
other categories of hypoglycemia events (if available) g
other clinical assessments
other samplings
"other t2dm treatment4,"
outcomes
outpatient visit
overnight fast
pagi-sym
pam
pancreatic amylase and lipase
"pancreatic amylase, lipase"
"pancreatic amylase, lipase, calcitonin, and tsh"
pancreatic enzymes
patient admission to cru
patient consultation with the investigator with respect to food boxes introduction
patient data
patient demographics
patient demography
patient diary review for glucometer values and/or
patient diary review for glucometer values/ hypoglycaemic events
"patient education, supplies, and smpg"
patient log sheets distributed
patient number assigned
patient registration
patient returns study drug and injection supplies
patient returns study drug vials
patient returns study drugs and/or injection supplies
patient returns unused study drug supplies
patient summary
patient to come fasting to study site
patient training
patient: global effectiveness scale
pcsk
pd samples for glucose j
pedometer distribution
pen collection/return
pen dispensing
pen training and start pen
pen-injector and self-injection training
perform 7-point smbg prior to site visit
perform hypoglycaemia fear survey-worry scale
perform iwqol-lite
perform sf-36 survey
peripheral blood draw for cd34+cell harvest
pg meter training
"pg meter, smpg training g"
"pg meter, smpg trainingh"
pg sampling e
pgx sampling (where applicable)
pharmacodynamic evaluations
pharmacodynamic samples
pharmacogenetic
pharmacogenetic sample
pharmacogenetic sample for storage
pharmacogenetic samples g
pharmacogenetic sampling
pharmacogenetic stored samples
pharmacogenomic consent
pharmacogenomic specimen
pharmacogenomic specimen°
pharmacogenomics sample (stored)
pharmacokinetic measurements
pharmacokinetics evaluations
pharmacy- per ip dispensation
phase a (double-blinded) study medication dispensing
phase b (open-label) study medication dispensing
phone calls
phone visit
physical
physical activity
physical activity and food frequency questionnaires*
physical exam
"physical exam (f, full; b, brief)"
physical exam:
physical exam²
physical exam³
physical examination
physical examination (height at screen only)
physical examination [8]
physical examination / anthropometrics
physical examination b
physical examination h
"physical examination, height, and weight"
physical examination:
physical examination/ medical assessment
physical examination°
physical examination³
"physical measurements (height, weight, vital signs)"
pk blood collection
pk for dapagliflozin
pk for metformin (prior to medi0382 dose as applicable)
pk sample for ertugliflozin'
"pk sample for immunogenicity"",pk sample for immunogenicity"""
pk samples
pk sampling
pk specific visita
placebo administration
placebo injection demonstration under staff supervisionb
placebo kit dispensation (for run-in)
plasma / serum
plasma and serum for future biomedical research
plasma and serum for future biomedical researche
plasma and serum for storage
plasma and serum sample for fbr¹
plasma concentration
plasma for future biomedical research
plasma for future biomedical research u
"plasma glucagon (fasting) m,p"
"plasma pk sample for liraglutide (potential analysis, for archive), bb"
plasma pk sample for mk-8521 bb
plasma volume
plasma volumep
"plasma, serum, and urine samples for exploratory analysis m"""
pmh
point profile
point- mmtt at selected sites: blood samples at 0 and 120 minutes sent for glucose
"point- mmtt at selected sites: blood samples at 0, 60, and 120 minutes sent for glucose, insulin, and glucagon"
population pk sampling
post-dose fasting routines
postural (orthostatic) blood pressure/pulse rate
postural (orthostatic) blood pressure/pulse rate (measured in duplicate)i
postural (orthostatic) blood pressure/pulse rate in duplicate
postural (orthostatic) blood pressure/pulse rate¹
postural (orthostatic)blood pressure and pulse rate
postural blood pressure
postural blood pressure/hrk
pre- and 2-hr post-prandial glucoseg
pre-albumin draw
pre-breakfast smpg (3 days prior to next contact)
pre-discontinuation of trial product
pre-dose blood sample
pre-dose pharmacokinetics for medi
pre-filled disposable pen (solostarr or flextouch®) and self-injection trainingc
preexisting conditions
preexisting conditions and adverse events
preexisting conditions/adverse events
preexisting conditions/adverse events e
pregnancy screen
pregnancy test
pregnancy test (blood sample)
pregnancy test (females with childbearing potential)
pregnancy test (for women of childbearing potential)b
pregnancy test (if applicable)
pregnancy test (in female)
pregnancy test (local measure)
pregnancy test (serum or urine)
pregnancy test (urine and serum if urine test positive) wocbp only
"pregnancy test (urine, wocbp only)"
"pregnancy test (urine, wocbp only)h"
pregnancy test (wocbp only)
pregnancy test (wocbp only)p
pregnancy test (wocbp)
pregnancy test (wocbp)k
pregnancy test (women of childbearing potential only)
pregnancy test [16]
pregnancy test b
pregnancy test c
pregnancy test d
pregnancy test e
"pregnancy test, urine dipsticks³"
pregnancy test/urine drug screen/alcohol breath test
pregnancy test¹
"pregnancy test7,"
pregnancy testd
pregnancy teste
pregnancy testf
pregnancy testing
pregnancy testk
pregnancy testp
pregnancy urine test
premature discontinuation criteria
premature discontinuation of trial products
prescribed insulin regimen
prescribing physician-relevant information: general/specialized practitioner
prescription of therapy and therapy and of compliance
prescription of trial product
prestudy therapy
pretreatment procedures
previous and concomitant medication
previous diabetes therapy
previous injection experience³
previous injection experiencea
previous insulin exposure
prior and/or concomitant medications
prior medication history
prior therapy reporting and review e
prior/concomitant medication review
prior/concomitant medications
prior/concomitant medications assessment
prior/concomitant treatments
pro qualitative questionst
pro questionnaires
"pro questionnaires (wrsm, appadl, iw- sp)"
pro questionnaires*
pro questionnaires¹
pro-insulin
procedure
procedures
product application
proinsulin°
provide container for urine collection for first morning void
provide diet and exercise counseling
provide dietary and exercise counseling
provide glucose meter and supplies / instructions
provide glucose meter and supplies/instructions for 7-point smbg
provide instructions for user
provide logs / instructions
provide subject diary/instructions
provide subject log to subject
provide subject with study contact card
provider: global effectiveness scale
providing smbg devise and instruction
pubertal assessments
pulmonary volumes
pulse rate and blood pressure (alone)
pulse wave analysis pulse wave velocity assessment
"pulse, sitting"
qd
quality of pain modified sf-mpq-2 inventory
quality of pain modified sf-mpq-2 inventory*
questionnaire for device
questionnaires
race/ethnicity
ramos registration
random (non-fasting) glucose
randomisation
randomisation (via irt)
randomisation (via ixrs)
randomisation and stratification
randomisation criteria
randomisation³
randomization
randomization (irt)n
randomization and stratification
randomization c
randomization to study treatment
randomization to study treatment via ivrs/iwrs
randomization/crossoveri
randomizationc
randomize
re-training on the bg meter use
reactive hyperemia
recent history / adverse event review
record 6-point smpg values e
record 6-point smpg valuesf
record body weight
record concomitant medications
record height
record pre-study serum creatinine
"record start time of breakfast, mid-day and evening meals"
"record start time of breakfast, mid-day, and evening meals"
recording of frc dose (u)
recording of glp-1 receptor agonist daily/weekly dose (mg or g ) (control arm)
recurrence assessment
ree
register actual glimepiride dosage in iwrs
register visit into ivrs
registration
registration and treatment
remind patient to fast prior to next clinic visit
remind patients about 6-point smpg
remind patients about 7-point smbg
reminders
remove cgm and download data
renal biomarkers g
renal function
"renal function parameters (creatinine, egfr)"
renal function test°
renal impairment history
renal panel
renal protocolf
rescue criteria
research bloods
respiratory polygraphy
retinal assessment
return double-blind imp and assess dosing adherence
return of study medication and accountability
return of unused diabetes medications and study supplies if required by local regulations
"return of used investigational product containers, unused study medication and study diary"
return single-blind imp and assess dosing adherence
return study diary
return study medication/ medication compliance check
return study medicationk
return to standard glycemic care if hyperglycemia relapse identified
"review ae/sae, concomitant and hypoglycemia events"
"review ae/sae, concomitant medication and hypoglycemia events"
review concomitant medication
review concomitant medications
review concomitant medications ee
review eligibility criteria (inclusion/exclusion criteria)
"review food log, completed for 3 days'"
"review food log, completed for 3 days¹"
review for i/e criteria¹
review in/exclusion criteria
review inclusion/exclusion criteria
review medical and surgical history
review medical history
review medical history requirements
review of adverse event and concomitant medication 5)
review of concomitant medications
review of diaries
review of hal and assessment of hypoglycemia
review of smbg measurements and hal
review of subcutaneous injection training
"review patient diaries for bg values, aes, hypoglycemic or hyperglycemic events"
review prior/concomitant medication°
review randomization criteria
review smbgs
review smpg values
review study diary
review study drug diary
review subject's diary and blood glucose measurements
"review use of any prohibited medications, including ahas; counsel patients on importance of not taking other ahas"
"review use of any prohibited medications, including ahas; counsel patients on importance of not taking other ahas¹"
"review use of any prohibited medications, including ahas; counsel subjects on importance of not taking other ahas"
review/discuss subject diary and smbg results
review/discuss subject diary and smbg resultsdd
review/dispense hypoglycemia assessment and self-monitoring blood glucose logs
review/record 6-point smpg valuesh
review/record hypoglycemic events
review/return study diary
routine clinical procedures
routine safety measurements
routine urinalysis¹ m
run-in compliance assessment
sae
safety
safety assessment
safety assessments
safety bloods
safety data
safety lab tests (urine and blood)
safety lab tests (urine and blood)h
safety laboratory
"safety laboratory' hematology, serum chemistry"
safety labs/measurements
"safety labs4,"
safety report(adr/sae/sadr/aesi)
samples for
satiety evaluation (vas) f
schedule of eye examination for next visit
screening (in-/exclusion)
screening for i/e criteria
screening laboratory tests d
screening labs
screening or confirmation for i/e criteria
screening/administrativ e
seated bp and pulse
seitq
self measured plasma
self measured plasma glucose
self measured plasma glucose (smpg)
self-measured blood glucose: 7-point profile³
self-measured plasma glucose
self-measured plasma glucose (7-point profile)
self-measured plasma glucose (smpg)
"self-measured plasma glucose, once or twice daily"
self-measurement blood glucose
self-monitored blood glucose f
self-monitoring blood glucose (smbg) instruction
self-monitoring of blood glucose
semaglutide pk sampling
semaglutide pk samplingd
semaglutide pke
"semi-recumbent vital signs (heart rate (hr), blood pressure (bp)),"
serious adverse events assessment
serology
"serology (hbsag, anti-hcv, anti-hiv-1 and -2)"
"serology (hep b, hep c)"
"serology for hepatitis b, c and hiv"
serum (s)/urine (u) pregnancy (wcbp)
serum (s)/urine (u) pregnancy test (wcbp)
serum alt
serum calcitonin
serum calcitonin level
serum calcitoning
"serum calcium, creatinine (gfr)"
serum chemistry
serum chemistry (predose)a
serum chemistry and electrolytes
serum chemistry electrolytes
serum chemistry hematology
serum chemistry panel
serum chemistry panel (predose as applicable)
"serum chemistry"",""
nct01032629,labs"""
serum chemistrym
serum chemistryst
serum creatinine
serum creatinine and cys-c
"serum cystatin c/serum creatinine f,g"
serum follicle stimulating hormone (fsh)
serum follicle stimulating hormone (fsh) - if applicable h
serum follicle stimulating hormone and estradiol (menopausal women only)
serum follicle stimulating hormone and estradiol (menopausal women onlyk
serum for future biomedical research
serum for future biomedical research u
serum fsh and estradiol (menopausal women only(central lab)
serum fsh and estradiol (menopausal women only)
serum insulin (fasting) m
serum ketones (b-hydroxybutyrate)
"serum lfts (ast, alt, total bilirubin, alkaline phosphatase)"
serum lipase
serum lipids
serum pregnancy test
serum pregnancy test (wcbp only)
serum pregnancy test h
serum pregnancy test j
serum pregnancy test/fsh¹
serum pregnancy test³
serum pregnancy/fsh¹
serum pregnancy9;
serum surfactant a protein
serum/urine pregnancy test (frp only)
seven-point glucose profile
"severe, nocturnal and total hypoglycemia events f"
sf-20 admin
sf-36v
sf36v
show and/or describe injection device
sign off casebook
sign-off case-book
signed and dated informed consent
single 12-lead ecg:
single supine 12-lead ecg
single supine vital signsb
single-blinded study medication dispensing
sitagliptin for the study dispensing
site fingerstick a1c measurement
"site fingerstick hba1c"",""
nct02033889,"",fasting fingerstick glucose in clinic"""
site fingerstick hba1c¹
site reaction
site visit
sitting blood pressure and pulse rate d
sitting blood pressure/pulse rate
sleep
smbg at each visits
smbg for those with diabetes
"smbg measurement and check logs15,"
smoking habits
smoking status
smpg measurements
smpg meter training
smpg to support insulin dose titrationk
smpg values review
smpg/
smpgf
snac pk sampling
"snac pke,f"
sns / arterial stiffness / non- invasive cardiac output monitoring
special lipids and other biomarkers
spot urine sample for urinary albumin and creatinine
ß-hcg (pregnancy test)
standard dinner
standard meals
standard mixed meal tolerance test/
standard safety laboratory panel (blood/urine)
standardized diabetic meals
standardized meal test with visual analog scale for appetite/satiety (vas)
standardized meals/snacks
start date of current diabetes treatment
start study medications
start wash-out
start washout
stop date of current diabetes treatment
stop date of current diabetes treatment b
stop diabetes medications
stored sample
stored samples
stored samples:
stored specimens
study and rescue medication
study completion
study diary review
"study diary, dispense"
study disposition
study drug
study drug accountability
study drug administration
study drug administration^
study drug and adherence
"study drug and injection supplies, dispense"
study drug dispensing
"study drug, assess compliance"
study drug/device
study drug/iwrs
study medication
study medication compliance
study medication compliance review
study medication dispensed
study medications (sitagliptin and/or ipragliflozin) compliance monitoring
study participants may resume pre- study insulin
study pill adherence
"study pill distribution, teaching"
study termination
study treatment
study treatment (q3w)
study treatment (qw)
study treatment administration
"study treatment administration training, (1st dose & 1st uptitration dose)"
study treatment compliance
study treatment dispensed
study treatment dispensed (daily dosing)
study treatment return
subcutaneous injection training
subcutaneous injection training/injection site inspection/review of technique
subject administration of oral dapagliflozin 10 mg
subject admission to cru
subject compliance
subject discharge from cru
subject education / monitoring
subject education/monitoring
subject experience / satisfaction exit questionairre
subject finger-prick testing of ketones using test strips
subject identification card
subject related info/assessment
"subject telephone contact (tc) to assess titration of metformin to 2,000mg"
subjects domiciled³
subjects fast prior to visit
supine 12-lead ecg°
supine vital signs
survey on self-administration of study drug g
switch rai to rhi in subjects randomized to rhi cohort
symptom-driven physical exam
systolic blood pressure
"systolic blood pressure, sitting"
t2dm diagnosis and previous t2dm treatments²
taken after titration
tanita scale
tanner staging
tanner staging (investigator determined/self-reported)
targeted physical examination
technical complaints
"technical complaints"",""
nct04007107,study procedures"""
"technical complaints"",""
nct04189848,study procedures"""
technical complaints¹
telemetry
telephone call by dietician
telephone call by dieticiane
telephone call for visit reminder or informing patient of completion in the study
telephone contact
telephone contact 1 day after dosing visit during treatment up-titration
telephone contact between clinic visits
telephone follow- up
telephone follow-up
temperature
"temperature, supine pulse & triplicate supine blood pressureb"
testosterone
tg
the final efficacy evaluation
three times daily
thyroid function (tsh and t4)
thyroid function tests [15]
thyroid panel
thyroid stimulating hormone (tsh)
thyroid-stimulating hormone (tsh) /total triiodothyronine (t3) /free thyroxine (ft4)
time of visit (weeks)
time spent in cru (hours)
timed urine sample collection (24- hours)
timepoints d
titrate insulin as applicable
titration phone calls (frc arm only) e
tobacco history/use
tobacco use
tobacco use (smoking status)
total and active glp-1/gip
total daily basal insulin dose
total daily prandial insulin dose
total ig and subsets (ig a/e/g/m)
total plasma lixisenatide concentration (only in frc group)p
"total-; ldl-; hdl-cholesterol, triglycerides*"
"training (glucometer, smpg profiles, hypoglycemia reporting e-diary)"
training in dosing instructions
training in trial product and pen
training in trial product and pen handling
training in trial product and pen handling.
training in trial product and pen handling¹
training in trial product dosing instructions
training in trial product handling and titration
"training in trial product, and pen handling"
"training in trial product, pen handling"
"training in trial product, pen-handling"
training in trial products and pen handling
"training in trial products, dosing instructions and pen handling"
training of glucometer and diary and smpg profilec
training of subject on glucose and ketone monitoring
training on signs/symptoms of hypo/hyperglycemia'
training or refresher instructions on glucose meter use and routine review of diet and lifestyle counseling along with instructions on dosage self-adjustment including carbohydrate intake¹
transfer diary data to ecrf (inform™
transfer diary information to ecrf:
treatment
treatment administration
treatment dispensed
treatment returned and compliance checked
treatment:
trial compliance
trial conduct
trial drug administration
trial material
trial termination
triglycerides
trim-d
trim-diabetes device
triplicate 12-lead ecg
triplicate sitting blood pressure/pulse rate
triplicate waist circumference
tsh
"tsh, (reflex to ft4)"
"tsh, amylase and lipase"
tumor history
tumor history³
two glucose profiles ****
two-hour standardized meal test (a sub-set of patients only)
uacr
uacr q
"uacr, egfr, sua and serum cystatin-c"
ultrasoundp
urinalysis
urinalysis (albumin:creatinine ratio)
urinalysis (dipstick and microscopy)
urinalysis (dipstick; predose as applicable)
urinalysis (dipstick)
urinalysis /
urinalysis 14]
urinalysis by stick
urinalysis incl. acr¹
"urinalysis k,"
urinalysis panel
"urinalysis, uacr d"
"urinalysis"",urinalysis"""
urinalysis[
urinalysis¹
urinalysise
urinalysish
urinary albumin:creatinine ratiom
urinary albumin/creatinine ratio
urinary albumin/creatinine ratio m
urinary albumin/creatinine ratiok
urine
urine 'drug' screen
"urine albumin, calcium, glucose & creatinine"
"urine albumin, creatinine, uacr"
urine albumin/creatinine ratio (acr) f
urine albumin/creatinine ratio (urinalysis)
urine albumin/creatinine ratio assessment (to be done on first morning urine sample)
"urine analysis, urine ß-hcg test in women of childbearing age"
urine analysis(central lab) k
urine bhcg
urine calcium-creatinine ratio
urine collection
urine collection (urinalysis and urinealbumin/creatinine ratio)
urine collection for dipstick/urinalysis¹
urine container dispense
urine dipstick
urine drug and alcohol screen
urine drug screen
urine drug screen (uds)
urine drug screening
urine ethanol and drug screen
urine for storage
urine pregnacy test (if applicable)
urine pregnancy
urine pregnancy test
urine pregnancy test - if applicable
urine pregnancy test (as applicable
urine pregnancy test (females of childbearing potential only)
urine pregnancy test (for females only)
urine pregnancy test (for premenopausal women)
"urine pregnancy test (local, wocbp only)"
urine pregnancy test (upt)
urine pregnancy test (wocbp)
urine pregnancy test (women of childbearing potential only )
urine pregnancy test (women of childbearing potential only)
"urine pregnancy test (women of childbearing potential only)"",""
nct02492763,"",plasma and serum for future biomedical researchd"""
urine pregnancy test k
"urine pregnancy test, qualitative"
urine pregnancy test³
urine pregnancy testh
urine pregnancy testing in central laboratory
urine sample
"urine sampling for glucose, microalbumin, copper, and zinc"
urine sampling for:
"urine ßhcg test (pregnancy test)"",""
nct03235050,labs"""
urine-spot
used/unused vial assessment
vas admin
venous blood a1c
venous fpg j
verify drug intake and drug accountability
"verify drug intake and drug accountability"",""
nct03152084,"",review of concomitant medications"""
verify eligibility criteria
verify eligibility criteriap
verify ip compliance
verify patient fasted 10 hours
verify subject has fasted 8 hours
viral serology (hepatitis)
visit date confirmation in e-diary web portal
visit window
visit window (days)
"vital sign (body weight, blood pressure, and pulse rate)"
vital sign (height)
"vital sign measurements,"
vital signs
vital signs - blood pressure & pulse
vital signs (3 sitting bp and pr measurements)
vital signs (3 sitting bp and pr measurements)d
"vital signs (blood pressure [sitting], heart rate [supine])"
"vital signs (blood pressure, heart rate)"
vital signs (bp and
vital signs (bp and hr measurements)f
vital signs (bp and pr)
vital signs (bp and pulse)
"vital signs (bp, heart rate, body temperature, rr) a"
"vital signs (bp, pulse, body temperature, rr) g"
"vital signs (bp, pulse)"
vital signs (bp/pr/temp)
"vital signs (heart rate, blood pressure) e"
vital signs (hr and blood pressure)
vital signs (including body weight)
"vital signs (pr and bp, in triplicate) i"
vital signs (pulse rate and blood pressure)
"vital signs (pulse rate, blood pressure, respiration rate, body temperature)"
vital signs (reclining/standing bp and hr)
"vital signs (respiratory rate, oral/temporal/tympanic temperature)"
"vital signs (respiratory rate, oral/tympanic temperature)"
vital signs (seated bp & heart rate)
vital signs (sitting) b
vital signs (supine and standing)
vital signs (supine)
vital signs (supine): blood pressure and pulse rate
vital signs (supine): blood pressure and pulse rateb
"vital signs (supine): body temperature, blood pressure and pulse rate"
vital signs / body weight
vital signs and body weight
vital signs d
vital signs in triplicate (pulse rate and blood pressure)
"vital signs measured in duplicate (heart rate, blood pressure)"
"vital signs, body weight"
"vital signs,¹ weight, foot examination"
vital signs: blood pressure and pulse rate
vital signs¹
vital signs²
vital signs³
vital signsc
vital signsd
vital signse
vital signse (supine)
vital signsf
vital signsh
wagner ulcer classification
waist / hip circumference
waist and hip circumference
waist and hip measurements
waist circumference
waist circumference -
waist circumferencelwhr
waist/hip circumference
waist/hip circumferencee
wash-out of existing raas therapy
washout lmt
washout second ahaw continue metformin monotherapy. do not change metformin dose
weight
weight (measured in duplicate)
weight a
weight and waist circumference³
weight c
weight in duplicate
weight j
weight/bmi c
weight/hip and waist circ/vital signs
weight/sbp/dbp/hr
weightd
whole blood (dna) for future biomedical research
whole blood (dna) for future biomedical research u
whole blood for dna
withdrawal criteria
withdrawal criterion
withdrawal from trial
withdrawal of consent
witness dose
witness dose of blinded investigational product / open-label liraglutide in clinic¹
witness dose of blinded investigational product in clinic
witness dose of blinded study drug in clinich
witness dose of blinded study medication and met- ir in clinic
witnessed dose of investigational product in clinic
women only : estradiol and fsh test (if necessary to confirm postmenopausal status)
women only : pregnancy test
women only: fsh (if necessary to define menopausal status)
women only: serum pregnancy test (if childbearing potential)
written general informed consent/assignment of sid number (e code)
written informed consent